Considering the high expression of SULF1 in primary breast cancer and in metastatic breast cancer with ERBB2 amplification, we further investigated mutations of SULF1 in breast cancer and their relationship with ERBB2 (HER2). This evidence concerns the gene SULF1 and breast carcinoma.